NPSP - NPS Pharmaceuticals Inc.

NPSP valuation $4.90 billion

Stock Price

Change: ↓ -0.05 (-0.108909%)
Last Update: 2015-01-30T16:16:47-05:00
Shares Outstanding: 106,839,708
Industry: Biotechnology

 NPS Pharma is a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases.

The company's current therapeutic areas of focus are gastrointestinal disease and endocrine disorders. These include Short Bowel Syndrome, a potentially fatal gastrointestinal disorder in which patients may have to rely on parenteral nutrition for their survival;

NPS Pharma continues to seek in-licensing opportunities to develop new therapies for a broad range of rare diseases, and complements its proprietary programs with a royalty-based portfolio of products and product candidates that includes agreements with Amgen, GlaxoSmithKline, Janssen Pharmaceuticals, and Kyowa Hakko Kirin. NPS Pharma has operations in the U.S., Canada, Europe, Latin America and Japan.

Stock Price Data

Open: 45.85 Previous Close: 45.91
High: 45.90 Low: 45.84
Bid: 45.84 Ask: 45.89

Bid Size: 600 Ask Size: 500
Raw Bid Size: 6 Raw Ask Size: 5
Trade Volume: 12174 Share Volume: 3806607
Last Trade Date: 2015-01-30 Last Trade Time: 16:14:56-05:00
Vwap: 45.8693873 EPS: 0.02

Fundamental Data

PE ratio: PB ratio: 37.285
Beta: 0.711025

52 Week High: 46.01 52 Week Low: 22.11
52 Week High Vwap: 45.9701 52 Week Low Vwap: 23.0887
52 Week High Volume: 81538400 52 Week Low Volume: 342823
52 Week Avg Volume: 2531311
* Quotes delayed 15 minutes

Related Stocks

StockCompany namePrice
GILD Gilead Sciences Inc. 104.83
IMGN ImmunoGen Inc. 7.63
CELG Celgene Corporation 119.16
ARNA Arena Pharmaceuticals Inc. 4.31
MNKD MannKind Corporation 6.35
AMGN Amgen Inc 152.26
NVAX Novavax Inc. 7.81
BIIB Biogen Idec Inc. 389.16
ARIA ARIAD Pharmaceuticals Inc. 6.45
PDLI PDL BioPharma Inc. 7.29